Brian Haymart

554 total citations
47 papers, 357 citations indexed

About

Brian Haymart is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Brian Haymart has authored 47 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 29 papers in Internal Medicine and 6 papers in Epidemiology. Recurrent topics in Brian Haymart's work include Atrial Fibrillation Management and Outcomes (43 papers), Venous Thromboembolism Diagnosis and Management (29 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Brian Haymart is often cited by papers focused on Atrial Fibrillation Management and Outcomes (43 papers), Venous Thromboembolism Diagnosis and Management (29 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Brian Haymart collaborates with scholars based in United States and Brazil. Brian Haymart's co-authors include Geoffrey D. Barnes, James B. Froehlich, Scott Kaatz, Eva Kline‐Rogers, J Kozłowski, Gregory D Krol, Xiaokui Gu, Steve Almany, Suman L. Sood and Jordan K. Schaefer and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

Brian Haymart

46 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Haymart United States 11 286 188 33 30 26 47 357
J Kozłowski United States 13 317 1.1× 157 0.8× 39 1.2× 28 0.9× 58 2.2× 47 405
M. Pfannkuche Germany 8 426 1.5× 150 0.8× 57 1.7× 72 2.4× 29 1.1× 16 515
Bipin Vadher United Kingdom 10 155 0.5× 156 0.8× 14 0.4× 30 1.0× 41 1.6× 19 400
Alexander C. Perino United States 8 292 1.0× 132 0.7× 39 1.2× 17 0.6× 28 1.1× 14 375
Christopher Ll. Morgan United Kingdom 7 220 0.8× 91 0.5× 55 1.7× 67 2.2× 41 1.6× 9 388
Pareen Vora Germany 13 153 0.5× 74 0.4× 36 1.1× 50 1.7× 60 2.3× 33 326
Ewa Mirek-Bryniarska Poland 13 287 1.0× 182 1.0× 39 1.2× 19 0.6× 57 2.2× 29 360
Rosalia Blanco United States 12 519 1.8× 169 0.9× 97 2.9× 81 2.7× 37 1.4× 27 623
David Parra United States 11 159 0.6× 56 0.3× 21 0.6× 18 0.6× 76 2.9× 24 322
C. van Walraven Canada 3 128 0.4× 71 0.4× 34 1.0× 10 0.3× 32 1.2× 3 228

Countries citing papers authored by Brian Haymart

Since Specialization
Citations

This map shows the geographic impact of Brian Haymart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Haymart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Haymart more than expected).

Fields of papers citing papers by Brian Haymart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Haymart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Haymart. The network helps show where Brian Haymart may publish in the future.

Co-authorship network of co-authors of Brian Haymart

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Haymart. A scholar is included among the top collaborators of Brian Haymart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Haymart. Brian Haymart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giuliano, Christopher, Brian Haymart, Scott Kaatz, et al.. (2025). Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study. The American Journal of Medicine. 138(12). 1671–1679.e5.
2.
Haymart, Brian, et al.. (2024). Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement. The American Journal of Medicine. 137(5). 449–453. 1 indexed citations
3.
Schaefer, Jordan K., Brian Haymart, Scott Kaatz, et al.. (2024). Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study. Research and Practice in Thrombosis and Haemostasis. 8(4). 102449–102449. 2 indexed citations
4.
5.
Haymart, Brian, Scott Kaatz, Stacy Ellsworth, et al.. (2024). Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems. Thrombosis and Haemostasis. 125(3). 278–285. 2 indexed citations
6.
Schaefer, Jordan K., Christopher Giuliano, Brian Haymart, et al.. (2023). Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study. Blood. 142(Supplement 1). 5129–5129. 1 indexed citations
7.
Haymart, Brian, et al.. (2023). Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation. Journal of Thrombosis and Thrombolysis. 55(4). 680–684. 3 indexed citations
8.
Haymart, Brian, Xiaokui Gu, Stephanie W. Watts, et al.. (2022). Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin. Journal of Thrombosis and Thrombolysis. 55(1). 141–148. 5 indexed citations
9.
Haymart, Brian, Scott Kaatz, Gregory D Krol, et al.. (2021). Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures. Thrombosis Research. 203. 27–32. 9 indexed citations
10.
Barnes, Geoffrey D., Yun Li, Xiaokui Gu, et al.. (2020). Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry‐based cohort study. Journal of Thrombosis and Haemostasis. 18(8). 2025–2030. 6 indexed citations
11.
Kurlander, Jacob E., Xiaokui Gu, James M. Scheiman, et al.. (2019). Missed opportunities to prevent upper GI hemorrhage: The experience of the Michigan Anticoagulation Quality Improvement Initiative. Vascular Medicine. 24(2). 153–155. 10 indexed citations
12.
Barnes, Geoffrey D., Brian Haymart, Eva Kline‐Rogers, et al.. (2018). Extended International Normalized Ratio testing intervals for warfarin‐treated patients. Journal of Thrombosis and Haemostasis. 16(7). 1307–1312. 9 indexed citations
13.
Barnes, Geoffrey D., Scott Kaatz, Elizabeth A. Jackson, et al.. (2017). Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics. Implementation Science. 12(1). 87–87. 18 indexed citations
14.
Schaefer, Jordan K., Suman L. Sood, Brian Haymart, et al.. (2017). Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants. Blood Advances. 1(26). 2536–2540. 9 indexed citations
15.
16.
Haymart, Brian, Xiaokui Gu, Eva Kline‐Rogers, et al.. (2016). Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant. Journal of Thrombosis and Thrombolysis. 43(2). 283–288. 21 indexed citations
17.
Putnam, Andrew J., Xiaokui Gu, Brian Haymart, et al.. (2015). The changing characteristics of atrial fibrillation patients treated with warfarin. Journal of Thrombosis and Thrombolysis. 40(4). 488–493. 4 indexed citations
18.
19.
Barnes, Geoffrey D., Xiaokui Gu, Brian Haymart, et al.. (2014). The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience. Thrombosis Research. 134(2). 294–299. 29 indexed citations
20.
Barnes, Geoffrey D., Scott Kaatz, Xiaokui Gu, et al.. (2012). Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). Journal of Thrombosis and Thrombolysis. 35(1). 10–14. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kozłowski Breakdown of academic impact, for papers by M. Pfannkuche Breakdown of academic impact, for papers by Bipin Vadher Breakdown of academic impact, for papers by Alexander C. Perino Breakdown of academic impact, for papers by Christopher Ll. Morgan Breakdown of academic impact, for papers by Pareen Vora Breakdown of academic impact, for papers by Ewa Mirek-Bryniarska Breakdown of academic impact, for papers by Rosalia Blanco Breakdown of academic impact, for papers by David Parra Breakdown of academic impact, for papers by C. van Walraven
Rankless by CCL
2026